Acta Haematologica

Papers
(The H4-Index of Acta Haematologica is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Systematic Review of Microthrombi in COVID-19 Autopsies39
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic31
Accelerated Phase of Myeloproliferative Neoplasms29
Hematological Manifestations among Patients with Rheumatic Diseases23
COVID-19 Coagulopathy: From Pathogenesis to Treatment18
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel18
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations18
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs12
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis12
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response11
Adherence to Immunization: Rebuttal of Vaccine Hesitancy10
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk10
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment10
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy10
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy10
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant10
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma10
0.0467369556427